JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathiesGina A. Montealegre Sanchez, Jonathan Janes, Adam Reinhardt et al.|Journal of Clinical Investigation|2018Cited by 519
KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for GlomerulonephritisLaurence H. Beck, Meryl Waldman, Laura Mariani et al.|American Journal of Kidney Diseases|2013Cited by 239